Should the NHS end its £330 million contract with Palantir?

A parliamentary committee has criticised the NHS’s £330 million contract with US firm Palantir, calling reliance on the company an unacceptable point of weakness. Palantir’s founder has criticised the concept of a national health service and the firm has issued political manifestos. The committee warned that government ambitions could be derailed by decisions taken abroad.